Bokf Raised its position in shares of UnitedHealth Group Incorporated (NYSE: UNH – Get Rating) by 3.0% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 87,046 shares of the healthcare conglomerate’s stock after buying an additional 2,546 shares during the quarter. UnitedHealth Group comprises 0.7% of Bokf Na’s portfolio, making its stock its 29th largest position. Bokf Na’s holdings in UnitedHealth Group were worth $ 43,709,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. OLD Mission Capital LLC bought a new position in shares of UnitedHealth Group during the third quarter valued at approximately $ 439,000. Camden National Bank grew its holdings in shares of UnitedHealth Group by 5.5% during the fourth quarter. Camden National Bank now owns 1,902 shares of the healthcare conglomerate’s stock valued at $ 667,000 after purchasing an additional 100 shares during the last quarter. Morgan Stanley grew its holdings in shares of UnitedHealth Group by 9.7% during the second quarter. Morgan Stanley now owns 8,693,237 shares of the healthcare conglomerate’s stock valued at $ 3,481,120,000 after purchasing an additional 768,188 shares during the last quarter. New World Advisors LLC bought a new position in shares of UnitedHealth Group during the third quarter valued at approximately $ 319,000. Finally, MFA Wealth Advisors LLC bought a new position in shares of UnitedHealth Group during the third quarter valued at approximately $ 126,000. Hedge funds and other institutional investors own 87.48% of the company stock.
A number of equities analysts recently issued reports on UNH shares. SVB Leerink increased their price objective on UnitedHealth Group from $ 550.00 to $ 600.00 and gave the stock an “outperform” rating in a report on Tuesday, April 19th. Cowen increased their price objective on UnitedHealth Group from $ 512.00 to $ 596.00 in a report on Monday, April 18th. Raymond James increased their price objective on UnitedHealth Group from $ 540.00 to $ 620.00 and gave the stock a “strong-buy” rating in a report on Tuesday, April 19th. Deutsche Bank Aktiengesellschaft increased their price target on UnitedHealth Group from $ 482.00 to $ 549.00 and gave the company a “buy” rating in a research note on Monday, April 18th. Finally, Cowen increased their price target on UnitedHealth Group from $ 512.00 to $ 596.00 in a research note on Monday, April 18th. Three equities research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have issued a strong buy rating to the company stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $ 555.73.
In other UnitedHealth Group news, Director Frederick William Mcnabb III bought 89 shares of the stock in a transaction on Thursday, May 26th. The shares were purchased at an average cost of $ 504.32 per share, with a total value of $ 44,884.48. Following the completion of the transaction, the director now directly owns 11,259 shares of the company stock, valued at approximately $ 5,678,138.88. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Richard T. Burke sold 3,000 shares of the stock in a transaction on Thursday, March 24th. The stock was sold at an average price of $ 508.80, for a total transaction of $ 1,526,400.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 12,000 shares of company stock valued at $ 6,001,485. 0.40% of the stock is owned by corporate insiders.
UNH opened at $ 452.06 on Friday. The stock has a fifty day moving average of $ 500.28 and a 200-day moving average of $ 490.29. The firm has a market capitalization of $ 424.11 billion, a P / E ratio of 24.74, a PEG ratio of 1.45 and a beta of 0.83. UnitedHealth Group Incorporated has a 12-month low of $ 383.12 and a 12-month high of $ 553.29. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 0.54.
UnitedHealth Group (NYSE: UNH – Get Rating) last released its earnings results on Thursday, April 14th. The healthcare conglomerate reported $ 5.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $ 5.40 by $ 0.09. UnitedHealth Group had a return on equity of 24.74% and a net margin of 5.86%. The company had revenue of $ 80.15 billion during the quarter, compared to analyst estimates of $ 78.77 billion. During the same quarter in the prior year, the company earned $ 5.31 earnings per share. The company revenue for the quarter was up 14.2% on a year-over-year basis. On average, analysts expect that UnitedHealth Group Incorporated will post 21.75 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 28th. Investors of record on Monday, June 20th will be issued a dividend of $ 1.65 per share. This represents a $ 6.60 annualized dividend and a dividend yield of 1.46%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $ 1.45. The ex-dividend date of this dividend is Thursday, June 16th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 31.75%.
About UnitedHealth Group: (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children’s health insurance and health care programs; health and dental benefits; and hospital and clinical services.
Receive News & Ratings for UnitedHealth Group Daily: – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.